New pneumonia vaccine shows promise in protecting little ones
NCT ID NCT06183216
First seen Feb 01, 2026 · Last updated May 13, 2026 · Updated 19 times
Summary
This study tested a new vaccine (PCV13) designed to protect children from serious infections caused by pneumococcal bacteria, such as pneumonia and meningitis. The trial involved 140 healthy infants (2 months old) and children (2–5 years old) to check the vaccine's safety and how well it triggers the body's defenses. Researchers compared the new vaccine to an existing one to see if it works just as well.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PNEUMOCOCCAL INFECTIOUS DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Binchuan County Center for Diseases Control and Prevention
Dali, Yunnan, 671600, China
Conditions
Explore the condition pages connected to this study.